699 related articles for article (PubMed ID: 28875492)
1. Innate and Adaptive Immune Cell Metabolism in Tumor Microenvironment.
Wu D
Adv Exp Med Biol; 2017; 1011():211-223. PubMed ID: 28875492
[TBL] [Abstract][Full Text] [Related]
2. Immune Cell Metabolism in Tumor Microenvironment.
Li Y; Wan YY; Zhu B
Adv Exp Med Biol; 2017; 1011():163-196. PubMed ID: 28875490
[TBL] [Abstract][Full Text] [Related]
3. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
4. CD147‑mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review).
Li X; Xu W
Oncol Rep; 2019 May; 41(5):2945-2956. PubMed ID: 30864716
[TBL] [Abstract][Full Text] [Related]
5. The role of AhR in transcriptional regulation of immune cell development and function.
Trikha P; Lee DA
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188335. PubMed ID: 31816350
[TBL] [Abstract][Full Text] [Related]
6. The cancer metabolic reprogramming and immune response.
Xia L; Oyang L; Lin J; Tan S; Han Y; Wu N; Yi P; Tang L; Pan Q; Rao S; Liang J; Tang Y; Su M; Luo X; Yang Y; Shi Y; Wang H; Zhou Y; Liao Q
Mol Cancer; 2021 Feb; 20(1):28. PubMed ID: 33546704
[TBL] [Abstract][Full Text] [Related]
7. Major fundamental factors hindering immune system in defense against tumor cells: The link between insufficiency of innate immune responses, metabolism, and neurotransmitters with effector immune cells disability.
Bahrambeigi S; Sanajou D; Shafiei-Irannejad V
Immunol Lett; 2019 Aug; 212():81-87. PubMed ID: 31260743
[TBL] [Abstract][Full Text] [Related]
8. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
Chou MY; Yang MH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
[TBL] [Abstract][Full Text] [Related]
9. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
Anari F; Ramamurthy C; Zibelman M
Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
[TBL] [Abstract][Full Text] [Related]
10. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
11. Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting.
Yu YR; Ho PC
Clin Exp Immunol; 2019 Aug; 197(2):153-160. PubMed ID: 30873592
[TBL] [Abstract][Full Text] [Related]
12. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression.
Zhang Q; Lou Y; Bai XL; Liang TB
World J Gastroenterol; 2018 Aug; 24(31):3500-3512. PubMed ID: 30131656
[TBL] [Abstract][Full Text] [Related]
13. Strategies to Interfere with Tumor Metabolism through the Interplay of Innate and Adaptive Immunity.
Mora J; Mertens C; Meier JK; Fuhrmann DC; Brüne B; Jung M
Cells; 2019 May; 8(5):. PubMed ID: 31083487
[TBL] [Abstract][Full Text] [Related]
14. The influence of microenvironment on tumor immunotherapy.
Zhang J; Shi Z; Xu X; Yu Z; Mi J
FEBS J; 2019 Nov; 286(21):4160-4175. PubMed ID: 31365790
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment.
Razmkhah M; Abtahi S; Ghaderi A
Curr Stem Cell Res Ther; 2019; 14(1):43-51. PubMed ID: 30112998
[TBL] [Abstract][Full Text] [Related]
16. The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.
Chang RB; Beatty GL
J Leukoc Biol; 2020 Jul; 108(1):363-376. PubMed ID: 32272502
[TBL] [Abstract][Full Text] [Related]
17. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
18. Innate immune mediators in cancer: between defense and resistance.
Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
[TBL] [Abstract][Full Text] [Related]
19. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy.
Lian X; Yang K; Li R; Li M; Zuo J; Zheng B; Wang W; Wang P; Zhou S
Mol Cancer; 2022 Jan; 21(1):27. PubMed ID: 35062950
[TBL] [Abstract][Full Text] [Related]
20. Cancer Immunity: Lessons From Infectious Diseases.
Trinchieri G
J Infect Dis; 2015 Jul; 212 Suppl 1(Suppl 1):S67-73. PubMed ID: 26116736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]